ZIM Laboratories Limited

NSE ZIMLAB.NS

ZIM Laboratories Limited Total Non-Current Liabilities for the year ending March 31, 2024: USD 5.83 M

ZIM Laboratories Limited Total Non-Current Liabilities is USD 5.83 M for the year ending March 31, 2024, a 57.46% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • ZIM Laboratories Limited Total Non-Current Liabilities for the year ending March 31, 2023 was USD 3.70 M, a 40.57% change year over year.
  • ZIM Laboratories Limited Total Non-Current Liabilities for the year ending March 31, 2022 was USD 2.64 M, a -12.28% change year over year.
  • ZIM Laboratories Limited Total Non-Current Liabilities for the year ending March 31, 2021 was USD 3.00 M, a -19.28% change year over year.
  • ZIM Laboratories Limited Total Non-Current Liabilities for the year ending March 31, 2020 was USD 3.72 M, a 16.71% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
NSE: ZIMLAB.NS

ZIM Laboratories Limited

CEO Dr. Chandrashekhar Mainde
IPO Date Nov. 25, 2022
Location India
Headquarters Sadoday Gyan
Employees 556
Sector Healthcare
Industries
Description

ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.

Similar companies

WINDLAS.NS

Windlas Biotech Limited

USD 11.16

-0.07%

YUKEN.NS

Yuken India Limited

USD 10.77

8.47%

ZOTA.NS

Zota Health Care Limited

USD 10.92

-0.24%

WENDT.NS

Wendt (India) Limited

USD 139.02

3.29%

XPROINDIA.NS

Xpro India Limited

USD 14.57

1.32%

StockViz Staff

February 2, 2025

Any question? Send us an email